Indonesia Digital Diabetes Management Market Segmentation by Product & Service (Device, and Services); by Device Type (Handheld, and Wearable Devices); by Diabetes Type (Type 1, and Type 2); and by End-User (Home Care Settings, Hospitals & Specialty Diabetes Clinics, Academic & Research Institutes, Sports & Gym Centers, and Others)-Demand Analysis & Opportunity Outlook 2020-2030
9 Jun 2022
Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022...
The Research Report is Updated with 2021 Base Year, 2022 Estimated year and Forecast till 2031 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2021 as base year, 2022 as estimated year and forecast to 2031. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Indonesia Digital Diabetes Management Market Highlights Over 2020 - 2030
The Indonesia digital diabetes management market is estimated to garner a revenue of USD 612.18 Million by the end of 2030, by growing at a CAGR of 17.97% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market in the nation registered a revenue of USD 117.71 Million. The growth of the market can be attributed primarily to the growing prevalence of diabetes in the nation which is driving the need for the adoption of diagnostic devices that can help in early detection of the disease. According to the statistics by the International Diabetes Federation (IDF), the number of people who have diabetes in the nation grew from 5654.3 Thousands in the year 2000 to 19465.1 Thousands in the year 2021. The statistics further stated that the prevalence of the disease amongst individuals in the nation is expected to reach 28569.9 Thousands by the end of 2045. Besides this, the growing advancement in information technology and the increasing adoption of IT in healthcare, which has given birth to several mobile health (mhealth) applications for use in smartphones or as smart wearables are also expected to poise significant growth opportunities for the market growth in the coming years.
The growth of the market can also be attributed to the growing number of individuals using the internet and the rising internet penetration in the nation. According to the statistics by the World Bank, the number of individuals using the internet as a share of the total population of Indonesia, increased from 10.92% in the year 2010 to 53.726% in the year 2020. On the other hand, the internet penetration rate in the nation is expected to cross by around 80% by the end of 2025. The market growth in the country can also be attributed to the growing adoption of smart wearables. Modern day smart wearables are equipped with numerous sensors that can detect several types of diseases and can share alerts when the optimum levels are reached.
Growth Drivers and Challenges Impacting the Growth of the Indonesia Digital Diabetes Management Market
Increasing Prevalence of Diabetes
Rising Demand for Mobile Health Apps
Growing Penetration of the Internet
Growing Adoption of Smart Wearables
High Cost of Devices
Rising Concern for Security
Indonesia Digital Diabetes Management Market Segmentation Synopsis
The Indonesia digital diabetes management market is segmented by product & service into device and services, out of which, the device segment is anticipated to garner the largest revenue by the end of 2030 and grow with a CAGR of 17.86% during the forecast period. By device type, the market is segmented into handheld devices, and wearable devices. Amongst these, the wearable devices segment is anticipated to garner the largest revenue by the end of 2030 and also grow with the highest CAGR of 18.24% during the forecast period. By diabetes type, the market is segmented into type 1 and type 2, out of which, the type 2 segment is anticipated to generate the largest revenue of USD 142.54 Million in the year 2022. By end-user, the market is segmented into home care settings, hospitals & specialty diabetes clinics, academic & research institutes, sports & gym centers, and others. Amongst these, the hospitals & specialty diabetes clinics segment is anticipated to garner the largest revenue of USD 214.14 Million by the end of 2030, up from a revenue of USD 40.19 Million in the year 2020.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the Indonesia digital diabetes management market that are included in our report are Brighter AB, F.Hoffmann-La Roche Ltd, Medtronic, Azumio Inc., Smart Meter LLC, Abbott, B. Braun Melsungen AG, Biocon, Becton, Dickinson and Company, and others.
Latest Developments in the Indonesia Digital Diabetes Management Market:
12th January, 2022: F.Hoffmann-La Roche Ltd announced that it has launched its professional blood glucose management solution with mobile digital health capabilities, known as the cobas pulse system.
13th April, 2021: B. Braun Melsungen AG announced that it has selected the provider of integration and API platform, Mulesoft to create a single 360-degree view of each patient and improve operational efficiencies.
Key Reasons to Buy Our Report
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
The report includes detailed company profiles of the major players dominating the market.
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
FREQUENTLY ASKED QUESTIONS
The increasing prevalence of diabetes, rising demand for mobile health apps, growing penetration of the internet, and the growing adoption of smart wearables are some of the major factors anticipated to drive the market growth.
The market is anticipated to attain a CAGR of 17.97% over the forecast period, i.e., 2021 – 2030.
The high cost of devices, along with the rising concern for security are estimated to hamper the market growth.
The major players in the market are Brighter AB, F.Hoffmann-La Roche Ltd, Medtronic, Azumio Inc., Smart Meter LLC, Abbott, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product & service, device type, diabetes type, and by end-user.
Which segment captures the largest market size in end-user segment in the Indonesia digital diabetes management market?
The hospitals & specialty diabetes clinics segment is anticipated to garner the largest revenue of USD 214.14 Million by the end of 2030 and display significant growth opportunities.
1. Market Definition
2. Assumptions and Acronyms
3. Research Methodology
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. Executive Summary – Indonesia Digital Diabetes Management Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Regulatory and Standards Landscape
9. Industry Risk Analysis
10. Pricing Analysis
11. Value Chain Analysis
12.Industry Growth Outlook
14.Impact of COVID-19 on the Digital Diabetes Management Market
15. Product Feature Analysis
17. Competitive Structure
17.1. Market Share Analysis, 2020
17.2. Competitive Benchmarking
17.3. Company Profiles
17.3.1. Brighter AB
17.3.2. F.Hoffmann-La Roche Ltd
17.3.4. Azumio Inc.
17.3.5. Smart Meter LLC
17.3.7. B. Braun Melsungen AG
17.3.9. Becton, Dickinson and Company
18.Indonesia Digital Diabetes Management Market Outlook 2020-2030
18.1. Market Overview
18.2. By Value (USD Million)
19.Indonesia Digital Diabetes Management Market – Segmentation Analysis 2020-2030
19.1. Product & Service
19.1.1. Device, 2020-2030F (USD Million)
220.127.116.11. Smart Glucose Meters, 2020-2030F (USD Million)
18.104.22.168. Continuous Glucose Monitoring (CGM) Systems, 2020-2030F (USD Million)
22.214.171.124. Smart Insulin Pumps, 2020-2030F (USD Million)
126.96.36.199.1. Tubeless/Patch Pump, 2020-2030F (USD Million)
188.8.131.52.2. Closed Loop Pump, 2020-2030F (USD Million)
184.108.40.206.3. Others, 2020-2030F (USD Million)
220.127.116.11. Smart Insulin Pens, 2020-2030F (USD Million)
18.104.22.168. Application, 2020-2030F (USD Million)
22.214.171.124.1. Diabetes & Blood Glucose Tracking Apps, 2020-2030F (USD Million)
126.96.36.199.2. Obesity & Diet Management Apps, 2020-2030F (USD Million)
188.8.131.52.3. Diabetes Management Software & Platform, 2020-2030F (USD Million)
19.2. Device Type
19.2.1. Handheld Devices, 2020-2030F (USD Million)
19.2.2. Wearable Devices, 2020-2030F (USD Million)
19.3. Diabetes Type
19.3.1. Type 1, 2020-2030F (USD Million)
19.3.2. Type 2, 2020-2030F (USD Million)
19.4.1. Home Care Settings, 2020-2030F (USD Million)
19.4.2. Hospitals & Specialty Diabetes Clinics, 2020-2030F (USD Million)
19.4.3. Academic & Research Institutes, 2020-2030F (USD Million)
19.4.4. Sports & Gym Centers, 2020-2030F (USD Million)
19.4.5. Others, 2020-2030F (USD Million)
Please enter your personal details below
- Brighter AB
- F.Hoffmann-La Roche Ltd
- Azumio Inc.
- Smart Meter LLC
- B. Braun Melsungen AG
- Becton, Dickinson and Company